The TGA has released a fifth Permissible Ingredients Determination for 2017, which is now included on the Federal Register of Legislation (FRL). It includes one new active probiotic ingredient for Listed Medicines. A combined volume of the six volume determination is included for CMA members in this update.

An amendment to the Therapeutic Goods Regulations has also been included on FRL, which allows for new kinds of notifications for Registered Complementary Medicines. The TGA Business Services online portal and guidance has been updated accordingly. For more details and links please click here.